Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
25%
Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Other(2)

Detailed Status

Completed2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (25.0%)
N/A3 (75.0%)

Trials by Status

completed250%
unknown250%

Recent Activity

0 active trials
Showing 4 of 4
unknownphase_3

Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicine Departments With Nutritional Care

NCT03802942
completednot_applicable

The Glycaemic Effects of Glucerna® in Critically Ill Patients.

NCT02594865
unknownnot_applicable

Clinical Evaluation of a Specific Enteral Diet for Diabetics

NCT01247714
completednot_applicable

Effect of Meal Replacement Beverage(Glucerna) on Body Composition,Lipid Metabolism and Blood Pressure

NCT02118389

Clinical Trials (4)

Showing 4 of 4 trials
NCT03802942Phase 3

Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicine Departments With Nutritional Care

Unknown
NCT02594865Not Applicable

The Glycaemic Effects of Glucerna® in Critically Ill Patients.

Completed
NCT01247714Not Applicable

Clinical Evaluation of a Specific Enteral Diet for Diabetics

Unknown
NCT02118389Not Applicable

Effect of Meal Replacement Beverage(Glucerna) on Body Composition,Lipid Metabolism and Blood Pressure

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4